{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"93","upperLimit":"100","value":"100"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"To measure CD33 donor chimerism at Day 30","dispersionType":"Full Range","groups":[{"description":"All patients will receive a haploidentical donor transplant using a conditioning regimen of Fludarabine (Flu), cyclophosphamide (cy) and total body irradiation (TBI) followed by MLN9708.\n\nMLN9708: MLN9708 will be given weekly x 3 weeks every 28 day cycles, for up to 12 cycles starting at D+5 post-transplant.","id":"OG000","title":"Haploidentical Transplant"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"30 days","title":"Day 30 CD33 Donor Chimerism","type":"SECONDARY","unitOfMeasure":"percentage of chimerism"}